We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Single-Handed Suturing Device Advances Vascular Surgery

By HospiMedica International staff writers
Posted on 19 Oct 2016
A disposable precision instrument enables surgeons to suture tubular and layered structures using just one hand, and at twice the speed of conventional suturing.

The Switch Platform is based on a straight needle positioned in a needle holder, which is placed inside a forceps-like device. More...
The needle is passed through the tissue, and is then recovered by a second needle holder on the other jaw of the forceps. The needle is then repositioned inside the needle holder and the process is repeated to the reverse direction; the procedure is thus repeated with every suture. This repetitive sequence allows for continuous suturing in a predictable linear path, resulting in less motion friction and damage to the vessel wall.

The Switch can be operated by lightly pinching the double-action buttons on the side with the thumb and index finger of one hand; the other hand is free to present the tissue to be sutured. The technique greatly improves the precision and efficiency of the suturing process, as surgeons no longer need to switch the needle between instruments, and can focus on getting control over the tissue instead. It also reduces operational time, as on average 30% of the operation time is spent on suturing.

Future developments include Switch devices with varying geometries; a micro surgery model for coronary artery and arteriovenous fistula procedures; laparoscopic and robotic variants; a reusable electrical model with exchangeable jaws; a 10 cm version; and diversification in suture material, including polydioxanone (PDS) and vicryl. The Switch is a product of Mellon Medical (Nijmegen, The Netherlands), and will initially focus on three vascular indications: carotid artery surgery, kidney transplant, and peripheral bypass surgery.

“By collaborating with medical specialists, industrial designers, and ergonomic experts in the development of the Switch, Mellon has been able to reinvent suturing, bringing suturing technology into the 21st century,” said vascular surgeon Mark Vrancken Peeters, MD, chief medical officer of Mellon Medical. “Our mission is to improve medical procedures by providing the best possible tools. We believe our innovative platform suturing technology will improve patient outcome and reduce overall healthcare costs.”

Related Links:
Mellon Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.